199 related articles for article (PubMed ID: 38583247)
1. Dual inhibition of oxidative phosphorylation and glycolysis to enhance cancer therapy.
Sheng X; Wang MM; Zhang GD; Su Y; Fang HB; Yu ZH; Su Z
Bioorg Chem; 2024 Jun; 147():107325. PubMed ID: 38583247
[TBL] [Abstract][Full Text] [Related]
2. Anticancer effect evaluation in vitro and in vivo of iridium(III) polypyridyl complexes targeting DNA and mitochondria.
Zhang H; Tian L; Xiao R; Zhou Y; Zhang Y; Hao J; Liu Y; Wang J
Bioorg Chem; 2021 Oct; 115():105290. PubMed ID: 34426145
[TBL] [Abstract][Full Text] [Related]
3. Mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes: synthesis, characterization, and anticancer properties.
Li Y; Liu B; Xu CX; He L; Wan YC; Ji LN; Mao ZW
J Biol Inorg Chem; 2020 Jun; 25(4):597-607. PubMed ID: 32232583
[TBL] [Abstract][Full Text] [Related]
4. An iridium (III) complex as potent anticancer agent induces apoptosis and autophagy in B16 cells through inhibition of the AKT/mTOR pathway.
Tang B; Wan D; Wang YJ; Yi QY; Guo BH; Liu YJ
Eur J Med Chem; 2018 Feb; 145():302-314. PubMed ID: 29331753
[TBL] [Abstract][Full Text] [Related]
5. Anticancer and antibacterial activity in vitro evaluation of iridium(III) polypyridyl complexes.
Yi QY; Zhang WY; He M; Du F; Wang XZ; Wang YJ; Gu YY; Bai L; Liu YJ
J Biol Inorg Chem; 2019 Mar; 24(2):151-169. PubMed ID: 30564887
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterization and anticancer activity in vitro and in vivo evaluation of an iridium (III) polypyridyl complex.
Yi QY; Wan D; Tang B; Wang YJ; Zhang WY; Du F; He M; Liu YJ
Eur J Med Chem; 2018 Feb; 145():338-349. PubMed ID: 29331805
[TBL] [Abstract][Full Text] [Related]
7. Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents.
Li J; Tian Z; Xu Z; Zhang S; Feng Y; Zhang L; Liu Z
Dalton Trans; 2018 Nov; 47(44):15772-15782. PubMed ID: 30357192
[TBL] [Abstract][Full Text] [Related]
8. Studies of anticancer activity in vitro and in vivo of iridium(III) polypyridyl complexes-loaded liposomes as drug delivery system.
Zhang WY; Du F; He M; Bai L; Gu YY; Yang LL; Liu YJ
Eur J Med Chem; 2019 Sep; 178():390-400. PubMed ID: 31202127
[TBL] [Abstract][Full Text] [Related]
9. Iridium(III) complexes conjugated with naproxen exhibit potent anti-tumor activities by inducing mitochondrial damage, modulating inflammation, and enhancing immunity.
Xie K; Lu XY; Zhu H; Zhu LY; Li RT; Ye RR
Dalton Trans; 2024 May; 53(20):8772-8780. PubMed ID: 38712840
[TBL] [Abstract][Full Text] [Related]
10. Highly Charged, Cytotoxic, Cyclometalated Iridium(III) Complexes as Cancer Stem Cell Mitochondriotropics.
Laws K; Eskandari A; Lu C; Suntharalingam K
Chemistry; 2018 Oct; 24(57):15205-15210. PubMed ID: 30052298
[TBL] [Abstract][Full Text] [Related]
11. Cyclometalated iridium(iii) complexes induce mitochondria-derived paraptotic cell death and inhibit tumor growth in vivo.
He L; Wang KN; Zheng Y; Cao JJ; Zhang MF; Tan CP; Ji LN; Mao ZW
Dalton Trans; 2018 May; 47(20):6942-6953. PubMed ID: 29721561
[TBL] [Abstract][Full Text] [Related]
12. The induction of apoptosis in SGC-7901 cells through the ROS-mediated mitochondrial dysfunction pathway by a Ir(III) complex.
Zhang C; Lai SH; Zeng CC; Tang B; Wan D; Xing DG; Liu YJ
J Biol Inorg Chem; 2016 Dec; 21(8):1047-1060. PubMed ID: 27796592
[TBL] [Abstract][Full Text] [Related]
13. Cyclometalated iridium(III) complexes as mitochondria-targeted anticancer and antibacterial agents to induce both autophagy and apoptosis.
Chen BB; Pan NL; Liao JX; Huang MY; Jiang DC; Wang JJ; Qiu HJ; Chen JX; Li L; Sun J
J Inorg Biochem; 2021 Jun; 219():111450. PubMed ID: 33826973
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of anticancer effect in vitro and in vivo of iridium(III) complexes on gastric carcinoma SGC-7901 cells.
Zhang WY; Wang YJ; Du F; He M; Gu YY; Bai L; Yang LL; Liu YJ
Eur J Med Chem; 2019 Sep; 178():401-416. PubMed ID: 31202128
[TBL] [Abstract][Full Text] [Related]
15. Anticancer Ir
Wu XW; Zheng Y; Wang FX; Cao JJ; Zhang H; Zhang DY; Tan CP; Ji LN; Mao ZW
Chemistry; 2019 May; 25(28):7012-7022. PubMed ID: 30913329
[TBL] [Abstract][Full Text] [Related]
16. Photoinduced anticancer activity studies of iridium(III) complexes targeting mitochondria and tubules.
Zhang WY; Yi QY; Wang YJ; Du F; He M; Tang B; Wan D; Liu YJ; Huang HL
Eur J Med Chem; 2018 May; 151():568-584. PubMed ID: 29656200
[TBL] [Abstract][Full Text] [Related]
17. In Vitro and In Vivo of Triphenylamine-Appended Fluorescent Half-Sandwich Iridium(III) Thiosemicarbazones Antitumor Complexes.
Shao M; Yao M; Liu X; Gao C; Liu W; Guo J; Zong J; Sun X; Liu Z
Inorg Chem; 2021 Nov; 60(22):17063-17073. PubMed ID: 34709784
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of anticancer effects in vitro of new iridium(III) complexes targeting the mitochondria.
Hao J; Zhang H; Tian L; Yang L; Zhou Y; Zhang Y; Liu Y; Xing D
J Inorg Biochem; 2021 Aug; 221():111465. PubMed ID: 33989986
[TBL] [Abstract][Full Text] [Related]
19. Increasing anticancer effect in vitro and vivo of liposome-encapsulated iridium(III) complexes on BEL-7402 cells.
Zhang Y; Fei W; Zhang H; Zhou Y; Tian L; Hao J; Yuan Y; Li W; Liu Y
J Inorg Biochem; 2021 Dec; 225():111622. PubMed ID: 34624670
[TBL] [Abstract][Full Text] [Related]
20. Cyclometalated iridium(III)-guanidinium complexes as mitochondria-targeted anticancer agents.
Song XD; Kong X; He SF; Chen JX; Sun J; Chen BB; Zhao JW; Mao ZW
Eur J Med Chem; 2017 Sep; 138():246-254. PubMed ID: 28668477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
